Showing results (181-190 of 5,696) with videos related to

Sort By:
Pageof 570
Medical Oncology (Northwood, London, England)|October 29, 2022
Treatment patterns and survival of patients with locoregional recurrence in early-stage NSCLC: a literature review of real-world evidenceKathleen Bowes, Nick Jovanoski, Audrey E Brown, et al.
Medical Oncology (Northwood, London, England)|October 29, 2022
Regulation of thymidylate synthase: an approach to overcome 5-FU resistance in colorectal cancerAdarsh Kumar, Ankit Kumar Singh, Harshwardhan Singh, et al.
Medical Oncology (Northwood, London, England)|September 29, 2022
Development of the T-ALLiPSC-based therapeutic cancer vaccines for T-cell acute lymphoblastic leukemiaZhu Li, Xuemei Chen, Luning Liu, et al.
Medical Oncology (Northwood, London, England)|October 12, 2022
In vitro cytotoxicity and anti-cancer drug release behavior of methionine-coated magnetite nanoparticles as carriersFaten Eshrati Yeganeh, Amir Eshrati Yeganeh, Mahdi Fatemizadeh, et al.
Medical Oncology (Northwood, London, England)|October 12, 2022
5-FU and the dietary flavonoid carvacrol: a synergistic combination that induces apoptosis in MCF-7 breast cancer cellsSaleh Azimi, Hamed Esmaeil Lashgarian, Vajihe Ghorbanzadeh, et al.
Medical Oncology (Northwood, London, England)|October 12, 2022
HDAC inhibitor Vorinostat and BET inhibitor Plx51107 epigenetic agents' combined treatments exert a therapeutic approach upon acute myeloid leukemia cell modelİlayda Alcitepe, Hilal Salcin, İlknur Karatekin, et al.
Medical Oncology (Northwood, London, England)|October 8, 2022
PRDX6 knockout restrains the malignant progression of intrahepatic cholangiocarcinomaHong Li, Zhengsheng Wu, Rulei Zhong, et al.
Medical Oncology (Northwood, London, England)|October 8, 2022
Myricetin-induced apoptosis in triple-negative breast cancer cells through inhibition of the PI3K/Akt/mTOR pathwayPreeti Sharma, Mohammad Ahmed Khan, Abul Kalam Najmi, et al.
Medical Oncology (Northwood, London, England)|September 7, 2022
Celastrol inhibits the migration and invasion and enhances the anti-cancer effects of docetaxel in human triple-negative breast cancer cellsZi Liu, Minghui Fan, Xiaojing Xuan, et al.
Medical Oncology (Northwood, London, England)|September 7, 2022
Anti-EGF nanobodies enhance the antitumoral effect of osimertinib and overcome resistance in non-small cell lung cancer (NSCLC) cellular modelsSalvador Guardiola, Macarena Sánchez-Navarro, Rafael Rosell, et al.
Pageof 570